Epidemiological, Clinical and Echocardiographic Aspects of Non-Obstructive Hypertrophic Cardiomyopathy in the Nephrology and Haemodialysis Department of the POINT G University Hospital  

作　　者：Hamadoun Yattara Nouhoum Coulibaly Yohana Koné Atabieme Kodio Seydou Sy Aboubacar Sidiki Fofana Abdou Messoum Dolo Djenebou Maiga Magara Samaké Alkaya Touré Abdoul Karim Traoré Mahamadoun Kougouliba Moustapha Tangara Sahare Fongoro Hamadoun Yattara;Nouhoum Coulibaly;Yohana Koné;Atabieme Kodio;Seydou Sy;Aboubacar Sidiki Fofana;Abdou Messoum Dolo;Djenebou Maiga;Magara Samaké;Alkaya Touré;Abdoul Karim Traoré;Mahamadoun Kougouliba;Moustapha Tangara;Sahare Fongoro(Point G University Hospital, Bamako, Mali;Sikasso Regional Hospital, Sikasso, Mali;Kayes Regional Hospital, Kayes, Mali;Segou Regional Hospital, Segou, Mali;Faculty of Medicine and Odontostomatology, University of Science, Technique and Technologies of Bamako, Bamako, Mali)

机构地区：[1]Point G University Hospital, Bamako, Mali [2]Sikasso Regional Hospital, Sikasso, Mali [3]Kayes Regional Hospital, Kayes, Mali [4]Segou Regional Hospital, Segou, Mali [5]Faculty of Medicine and Odontostomatology, University of Science, Technique and Technologies of Bamako, Bamako, Mali

出　　处：《Open Journal of Nephrology》2023年第2期81-90,共10页肾脏病（英文）

摘　　要：Introduction: LVH is the earliest cardiovascular abnormality in CKD. It is a significant risk factor for mortality and cardiovascular morbidity in patients with chronic kidney disease. The objective of this study was to investigate non-obstructive hypertrophic cardiomyopathy in CKD patients hospitalised in the nephrology and haemodialysis department of the POINT G University Hospital. Methods: This is a prospective study carried out from January 1, 2021 to December 31, 2021 and concerned chronic renal failure patients with non-obstructive hypertrophic cardiomyopathy. Results: During our study, we recorded 89 cases of non-obstructive hypertrophic cardiomyopathy, a prevalence of 42.8%. The sex ratio was 1.2 in favour of men. The average age of the patients was 45 ± 14.4 years with extremes of 16 and 78 years. The risk factors frequently found were anaemia (100%) and hypertension (92.1%). The clinical picture was dominated by the left heart failure syndrome (66.3% of cases). The different types of echocardiographic hypertrophy found were concentric (72%), eccentric (18%) and septal hypertrophy (10%). Conclusion: Non-obstructive hypertrophic cardiomyopathy is the early cardiovascular abnormality encountered in CKD. It is associated with cardiovascular risk factors such as hypertension, anaemia and phosphocalcic disorders.Introduction: LVH is the earliest cardiovascular abnormality in CKD. It is a significant risk factor for mortality and cardiovascular morbidity in patients with chronic kidney disease. The objective of this study was to investigate non-obstructive hypertrophic cardiomyopathy in CKD patients hospitalised in the nephrology and haemodialysis department of the POINT G University Hospital. Methods: This is a prospective study carried out from January 1, 2021 to December 31, 2021 and concerned chronic renal failure patients with non-obstructive hypertrophic cardiomyopathy. Results: During our study, we recorded 89 cases of non-obstructive hypertrophic cardiomyopathy, a prevalence of 42.8%. The sex ratio was 1.2 in favour of men. The average age of the patients was 45 ± 14.4 years with extremes of 16 and 78 years. The risk factors frequently found were anaemia (100%) and hypertension (92.1%). The clinical picture was dominated by the left heart failure syndrome (66.3% of cases). The different types of echocardiographic hypertrophy found were concentric (72%), eccentric (18%) and septal hypertrophy (10%). Conclusion: Non-obstructive hypertrophic cardiomyopathy is the early cardiovascular abnormality encountered in CKD. It is associated with cardiovascular risk factors such as hypertension, anaemia and phosphocalcic disorders.

关 键 词：LVH Risk Factor Chronic Renal Failure Echocardiography 

分 类 号：R54[医药卫生—心血管疾病]